UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.
Most popular content
Rate for better recommendations!
Your feedback helps us show you more of what you like and less of what you dislike!
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
Panel discussion: Cancer and IBD - Mitigating risk among uncertainty
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
… after ileocecal resection of localised Crohn's disease
Affiliations
1 Saint-Louis Hospital, AP-HP, Université Paris Cité, Paris, France
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
Detection and management of dysplasia in UC
Affiliations
1 University College Cork, Cork, Ireland
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
From H. pylori to cancer:Optimising current antibiotic therapy and exploring future targeted treatments
Affiliations
1 Trinity College Dublin, Dublin, Ireland
2 UZ Leuven, Leuven, Belgium
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
Resmetirom and novel biomarkers
Affiliations
1 Charité Universitaetsmedizin Berlin, Dept of Hepatology & Gastroenterology, Berlin, Germany
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
REAL-LIFE VS CLINICAL TRIAL ACCESS TO BIOLOGICAL THERAPY: FINDINGS FROM AN ITALIAN-AMERICAN STUDY ON INFLAMMATORY BOWEL DISEASE
Federica Di Vincenzo 1, Stephanie Ioannou 2, Chiara Principessa 3, Ivan Capobianco 1, Antonio Gasbarrini 4, Lucrezia Laterza 4, Maria T. Abreu 5, Franco Scaldaferri 4
Affiliations
1 Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
2 University of Miami - Jackson Health System, Miami, United States
3 Università Cattolica del Sacro Cuore, Roma, Italy
4 Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
5 University of Miami Miller School of Medicine, Department of Medicine, Division of Gastroenterology, Miami, FL 33136; F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, United States
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
Will molecular targeted therapies become the new gold-standard in PC
Affiliations
1 Medical University Hospital Tuebingen, Tübingen, Germany